Literature DB >> 647548

Estrogen use and cancer of the uterine corpus in Alberta.

D T Wigle, M Grace, E S Smith.   

Abstract

Entities:  

Keywords:  Acceptor Characteristics; Age Factors; Americas; Canada; Cancer; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents--side effects; Demographic Factors; Developed Countries; Diseases; Endometrial Cancer--etiology; Epidemiologic Methods; Family Planning; Incidence; Measurement; Neoplasms; North America; Northern America; Oral Contraceptives; Population; Population Characteristics; Research Methodology

Mesh：

Substances：

Year:  1978        PMID： 647548      PMCID： PMC1818636     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

2.  Increasing incidence of endometrial cancer in the United States.

Authors:  N S Weiss; D R Szekely; D F Austin
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

3.  Estrogen and endometrial carcinoma. An independent pathology review supporting original risk estimate.

Authors:  J Gordon; J W Reagan; W D Finkle; H K Ziel
Journal:  N Engl J Med       Date:  1977-09-15       Impact factor: 91.245

4.  The occurrence of lung cancer in man.

Authors:  M L LEVIN
Journal:  Acta Unio Int Contra Cancrum       Date:  1953

5.  Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting.

Authors:  J Coope; J M Thomson; L Poller
Journal:  Br Med J       Date:  1975-10-18

6.  Association of exogenous estrogen and endometrial carcinoma.

Authors:  D C Smith; R Prentice; D J Thompson; W L Herrmann
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245
  6 in total
  6 in total

Review 1.  Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.

Authors:  M K Goddard
Journal:  Br J Gen Pract       Date:  1992-03       Impact factor: 5.386

Review 2.  [The role of progestins].

Authors:  H I Wyss
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  Screening for endometrial cancer.

Authors:  J A Nisker
Journal:  Can Fam Physician       Date:  1983-05       Impact factor: 3.275

4.  The menopause.

Authors:  P F Brenner
Journal:  West J Med       Date:  1982-03

5.  Mortality for cancer of the corpus uteri.

Authors:  A B Miller
Journal:  Can Med Assoc J       Date:  1978-12-09       Impact factor: 8.262

Review 6.  Estrogen replacement therapy (ERT) in high-risk cancer patients.

Authors:  K A Hutchinson-Williams; J N Gutmann
Journal:  Yale J Biol Med       Date:  1991 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.